Medically Reviewed By: Halo Concierge Health
There is no single GLP-1 medication that is best for every person trying to lose weight. The right choice depends on your medical history, weight-loss goals, metabolic risks, side effect profile, medication access, and how your body responds over time.
Some people do better with a semaglutide-based option, while others respond better to or tolerate a tirzepatide-based option, which works through both GIP and GLP-1 pathways. A physician-led plan should compare expected benefits with safety, tolerability, nutrition, muscle preservation, and long-term sustainability.
GLP-1 stands for glucagon-like peptide-1, a hormone signal that helps regulate appetite, fullness, insulin release, blood sugar, and stomach emptying. GLP-1 receptor agonists are medications that activate this pathway. For weight loss, they can help reduce appetite, increase fullness, and make it easier for some patients to stay consistent with a nutrition plan.
Semaglutide is one of the best-known GLP-1 receptor agonists used in medical weight-loss care. Liraglutide is another GLP-1 medication, though it is typically dosed differently and is used less often in many modern weight-loss settings. Tirzepatide is often grouped into the same conversation because it affects the GLP-1 pathway, but it also activates the GIP pathway, which may influence appetite, insulin response, and weight loss.
Clinical trials have shown meaningful average weight loss with semaglutide, liraglutide, and tirzepatide in adults with overweight or obesity. Tirzepatide trials have generally shown larger average weight-loss percentages than older GLP-1-only trials, but that does not automatically make it the right choice for every person. Trial averages are not the same as personalized care.
The practical question is not just, “Which medication produces the most weight loss on paper?” A better question is, “Which medication is safest, most tolerable, most effective, and most sustainable for this patient?” That is where medical review and follow-up matter.
Choosing a GLP-1 or GLP-1-related medication starts with a clinical evaluation. This usually includes weight history, prior weight-loss attempts, eating patterns, activity level, medical conditions, family history, current medications, and symptoms that may affect appetite, digestion, hormones, sleep, or energy. The goal is to understand why weight gain or weight-loss resistance is happening, not just to prescribe a medication.
The next step is determining whether medication is appropriate at all. Some patients meet criteria for medical weight-loss therapy and may be good candidates. Others may need a different starting point, such as addressing thyroid issues, sleep apnea, stress, alcohol intake, medication-related weight gain, menopause-related changes, or uncontrolled blood sugar patterns.
If medication is appropriate, the clinician considers which option fits best. Semaglutide may be a good fit for some patients based on history, access, tolerability, and expected benefit. Tirzepatide may be considered for others, especially when the clinical picture suggests that a dual GIP/GLP-1 pathway approach may be appropriate. Liraglutide or other options may also be relevant in select cases.
Dosing usually starts low and increases gradually. This helps reduce gastrointestinal side effects such as nausea, constipation, vomiting, diarrhea, bloating, reflux, or early fullness. Slower dose increases may be needed for patients who are sensitive to medication changes or who develop side effects early.
Follow-up is where the plan becomes individualized. A patient may respond well and stay on the same path. Another patient may need a dose adjustment, nutrition support, more hydration and protein guidance, treatment for constipation, or a change in medication if side effects or results are not acceptable.
GLP-1-based medical weight loss may be appropriate for adults with obesity or for adults with excess weight and weight-related health risks. It may also be considered when weight is affecting blood sugar, blood pressure, cholesterol, inflammation, mobility, energy, sleep, or long-term cardiometabolic risk. The best candidates are usually patients who want structured medical guidance and are willing to participate in nutrition, movement, and follow-up.
Patients who are looking for a quick fix may not be a good fit. These medications can help reduce appetite, but they do not replace protein intake, strength training, sleep, metabolic monitoring, or long-term behavior change. Without structure, patients may lose muscle, under-eat, become constipated, or regain weight after stopping therapy.
Extra caution is important for patients with a history of pancreatitis, significant gallbladder disease, severe gastrointestinal motility problems, active eating disorder concerns, dehydration risk, kidney disease, or complex diabetes medication regimens. Patients taking insulin or sulfonylureas may need closer glucose monitoring because blood sugar can drop too low when therapies are combined.
Pregnancy planning also matters. Patients who are pregnant, trying to become pregnant, or breastfeeding should discuss this directly with a clinician because GLP-1 medications are generally not used in those situations unless a qualified clinician determines otherwise. Patients planning surgery or a procedure involving anesthesia should also disclose GLP-1 use because delayed stomach emptying can affect pre-procedure instructions.
For Halo patients, the ideal fit is someone who wants a physician-led metabolic strategy rather than a one-off prescription. Weight loss is part of the goal, but so are energy, resilience, healthspan, body composition, and safer long-term maintenance.
The most common side effects of GLP-1 and GLP-1-related medications are digestive. Nausea, constipation, diarrhea, vomiting, reflux, bloating, reduced appetite, and early fullness can occur, especially during dose increases. These effects are often manageable, but they should be taken seriously if they interfere with hydration, nutrition, work, sleep, or daily function.
Another limitation is that appetite suppression can work too well. Some patients unintentionally eat too little protein or too few total nutrients. Over time, this can contribute to fatigue, weakness, hair shedding, constipation, and loss of lean muscle if the plan does not include nutrition and strength support.
Gallbladder problems and pancreatitis are less common but important safety concerns. Persistent upper abdominal pain, pain that moves to the back, fever, ongoing vomiting, or yellowing of the skin or eyes should be evaluated promptly. Patients with a prior history of these conditions need an individualized risk discussion before starting therapy.
Low blood sugar is not usually the main issue when GLP-1 medications are used alone in patients without diabetes. However, the risk can increase when they are combined with insulin or sulfonylurea medications. Symptoms such as shakiness, sweating, confusion, fast heartbeat, weakness, or faintness should be addressed according to the patient’s care plan.
Monitoring may include weight trend, waist measurement, body composition when available, blood pressure, blood sugar or A1C when relevant, kidney and liver markers when clinically appropriate, side effects, nutrition quality, hydration, bowel function, and strength maintenance. The medication choice should be revisited over time because the “best” option at the beginning may not remain the best option forever.
Seek urgent medical care for severe or persistent abdominal pain, especially if it radiates to the back or comes with vomiting, fever, or yellowing of the skin or eyes. These symptoms may point to pancreatitis or gallbladder disease and should not be managed casually at home.
Urgent care is also appropriate for fainting, confusion, symptoms of severe dehydration, chest pain, shortness of breath, severe allergic reaction, or low blood sugar symptoms that do not improve with your care plan. If symptoms feel sudden, severe, or unsafe, call emergency services.
If you are trying to decide which GLP-1 or GLP-1-related option is right for weight loss, Halo Concierge Health can help you compare the options through the lens of your medical history, goals, side effects, and long-term metabolic health. Ready to talk it through? Book a discovery consult to see if this is a fit for you. Or learn more about Halo’s medical weight loss approach in Raleigh, NC.
Helping people live a more balanced & healthier life isn't just our job, it's our passion! We believe that having hormone balance is key for lifelong, optimal health + wellness, and we take our mission very seriously... incorporating the latest scientific advances and dedicated to the very best care possible.
Halo Concierge Health is located in Raleigh, NC and serves practice members throughout North Carolina and Virginia. These areas include but are not limited to Raleigh, Wake Forest, Durham, Chapel Hill, Cary, Morrisville, Apex, Holly Springs, Fuquay-Varina, Garner, Clayton, Rolesville, Zebulon, and Mebane with options for follow-up telemedicine appointments.